Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice

https://doi.org/10.1016/S0002-9149(00)01505-8Get rights and content

First page preview

First page preview
Click to open first page preview

References (12)

There are more references available in the full text version of this article.

Cited by (0)

This study was supported in part by AstraZeneca, Wedel, Germany; Bristol-Myers Squibb, München, Germany; Knoll AG, Ludwigshafen, Germany; the Landesversichenrungsanstalt, Rheinland-Pfalz, Germany; and the Ministerum für Arbeit, Soziales und Gesundheit, Rheinland-Pfalz, Germany.

View full text